Serina Therapeutics Balance Sheet (2017-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)	0.67M	0.78M	0.58M	0.40M	0.70M	0.47M	0.65M	0.28M	0.26M	0.40M	7.62M	8.71M	6.06M	3.19M	3.67M	4.30M	6.00M	8.62M	3.06M	23.02M
Cash & Current Investments (Quarter)	0.67M	0.78M	0.58M	0.40M	0.70M	0.47M	0.65M	0.28M	0.26M	0.40M	7.62M	8.71M	6.06M	3.19M	3.67M	4.30M	6.00M	8.62M	3.06M	23.02M
Receivables - Net (Quarter)	0.01M	0.02M	0.03M		0.01M	0.00M	0.00M	0.01M	0.01M	0.07M		0.07M	0.05M	0.01M
Receivables - Other (Quarter)								-0.09M	-0.20M	0.66M	0.17M	-0.16M
Receivables (Quarter)	0.01M	0.02M	0.03M		0.01M	0.00M	0.00M	-0.08M	-0.19M	0.73M	0.17M	-0.10M	0.05M	0.01M
Prepaid Assets (Quarter)	0.93M	0.72M	1.62M	1.38M	1.01M	0.72M	1.80M	1.46M	1.08M	0.67M		0.17M	2.80M	0.14M	0.08M	1.49M	0.18M	0.17M	0.31M	2.01M
Current Assets (Quarter)	1.56M	1.48M	2.23M	1.83M	1.73M	1.19M	2.45M	1.75M	1.35M	1.14M	7.62M	8.94M	8.92M	5.42M	5.68M	5.75M	7.99M	11.50M	6.08M	25.03M
Non-Current Assets
Construction in Progress (Quarter)
Property, Plant & Equipment (Net) (Quarter)											0.57M	0.56M	0.54M	0.52M	0.50M	0.48M	0.59M	0.58M	0.47M	0.48M
Intangibles (Quarter)	0.94M	0.90M	1.31M	0.84M	0.80M	0.77M	0.74M	0.70M	1.31M	0.64M		0.58M	0.54M	0.51M
Goodwill & Intangibles (Quarter)	0.94M	0.90M	1.31M	0.84M	0.80M	0.77M	0.74M	0.70M	1.31M	0.64M		0.58M	0.54M	0.51M
Other Non-Current Assets (Quarter)	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M		0.05M	0.05M	0.33M				0.02M	0.03M	0.03M
Non-Current Assets (Quarter)	0.98M	0.95M	0.92M	0.89M	0.85M	0.82M	0.79M	-1.25M	-0.85M	11.07M	1.35M	1.92M	1.79M	2.01M	1.05M	0.98M	0.95M	0.92M	0.87M	0.78M
Assets (Quarter)	2.54M	2.43M	3.15M	2.72M	2.58M	2.01M	3.24M	0.50M	0.50M	12.21M	8.97M	10.86M	10.71M	7.43M	6.72M	6.73M	8.94M	12.41M	6.95M	25.81M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	1.30M	0.92M	0.77M	0.50M	0.16M	0.79M	1.03M	1.26M	0.96M	1.17M	0.58M	4.01M	1.97M	1.70M	0.74M	1.19M	1.71M	2.73M	1.93M	1.86M
Payables (Quarter)	1.30M	0.92M	0.77M	0.50M	0.16M	0.79M	1.03M	1.26M	0.96M	1.17M	0.58M	4.01M	1.97M	1.70M	0.74M	1.19M	1.71M	2.73M	1.93M	1.86M
Accumulated Expenses (Quarter)	0.62M	0.54M	0.21M	0.18M	0.17M	0.26M	0.27M	0.20M	0.26M	0.29M	0.58M	1.30M	0.32M	1.16M	1.43M	0.98M	1.31M	1.14M	1.21M	1.36M
Other Accumulated Expenses (Quarter)							0.14M	0.14M	0.23M		0.25M	0.00M	0.01M	0.20M	0.19M	0.18M	0.55M	0.35M	0.34M	0.55M
Short term Debt (Quarter)	3.56M	5.60M	7.14M	6.66M	6.97M	0.06M	7.65M	20.04M	22.94M	1.53M		9.75M	10.45M	10.46M				2.89M
Current Leases (Quarter)											0.04M	0.21M	0.20M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	5.27M	6.60M	8.97M	10.10M	9.09M	8.81M	10.08M	22.52M	24.50M	3.20M	1.41M	14.06M	12.63M	13.51M	2.37M	2.35M	3.56M	8.79M	3.56M	3.76M
Non-Current Liabilities
Capital Leases (Quarter)											0.00M
Non-Current Debt (Quarter)	5.56M	5.81M	6.06M	4.21M	6.76M	8.35M	10.48M	10.01M	10.07M	0.69M		0.69M	0.69M	0.69M
Convertible Debt (Quarter)											2.98M								2.95M	3.09M
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)										-14.82M	36.40M
Minority Interest (Quarter)	-0.04M	-0.04M	-0.04M	-0.04M	-0.04M	-0.04M	-0.10M	-0.11M	-0.12M	-0.11M	36.40M		-0.03M	-0.05M	-0.13M	-0.14M	-0.16M	-0.17M
Liabilities from Discontinued Operations (Quarter)
Operating Leases (Quarter)											0.68M	0.41M	0.36M	0.51M	0.27M	0.41M	0.36M	0.31M	0.38M	0.12M
Other Non-Current Liabilities (Quarter)				1.61M	1.03M	0.66M	0.18M	0.35M		0.10M		24.08M	13.41M	6.74M	3.58M	2.59M	3.55M	1.88M	0.28M	0.11M
Total Non-Current Liabilities (Quarter)				12.69M	14.81M	16.50M	20.38M	32.19M		3.80M	4.86M	-8.91M	13.69M	14.52M	2.63M	2.58M	3.75M	8.94M	6.71M	6.97M
Total Liabilities (Quarter)	10.84M	12.40M	15.03M	14.31M	15.84M	17.16M	20.56M	32.54M	34.57M	3.90M	4.86M	15.16M	27.10M	21.26M	6.22M	5.17M	7.29M	10.82M	6.99M	7.08M
Shareholder's Equity
Total Debt (Quarter)	9.12M	11.41M	13.20M	10.87M	13.72M	8.41M	18.12M	30.05M	33.01M	2.22M		10.44M	11.14M	11.15M				2.89M
Common Equity (Quarter)	-8.29M	-9.98M	-11.88M	-11.59M	-13.26M	-15.15M	-37.78M	-36.12M	-35.29M	-33.35M	-32.29M	-28.39M	-16.39M	-13.83M	0.64M	1.56M	1.65M	1.59M	-0.04M	18.73M
Liabilities and Shareholders Equity (Quarter)	2.54M	2.43M	3.15M	2.72M	2.58M	2.01M	3.24M	0.50M	0.50M	12.21M	8.97M	10.86M	10.71M	7.43M	6.72M	6.73M	8.94M	12.41M	6.95M	25.81M
Retained Earnings (Quarter)	-101.60M	-103.59M	-105.75M	-108.50M	-111.07M	-113.51M	99.00M	-119.50M	-122.20M	100.02M	0.88M	-48.19M	-42.99M	-41.58M	-44.32M	50.83M	-55.58M	-0.00M	-63.50M	95.48M
Preferred Shares (Quarter)																	4.94M	4.94M	4.94M
Treasury Shares (Quarter)	0.02M	0.02M	0.02M	0.01M	0.01M	0.01M	3.32M	3.32M	3.32M	3.44M	3.44M

Research Tools

Datasets

Plans

Developers

Serina Therapeutics SER Balance Sheet (2017-2026)

Research Tools

Datasets

Plans

Developers

Serina Therapeutics SER Balance Sheet (2017-2026)

Create an account

Sign In

Reset Password